Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rosiglitazone: a case of regulatory hubris.

× No keyword cloud information.

5 in total

Review 1. Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates.

Authors: Lee Aymar Ndounga Diakou; Ludovic Trinquart; Asbjørn Hróbjartsson; Caroline Barnes; Amelie Yavchitz; Philippe Ravaud; Isabelle Boutron
Journal: Cochrane Database Syst Rev Date: 2016-03-10

Review 2. Are Corporations Re-Defining Illness and Health? The Diabetes Epidemic, Goal Numbers, and Blockbuster Drugs.

Authors: Linda M Hunt; Elisabeth A Arndt; Hannah S Bell; Heather A Howard
Journal: J Bioeth Inq Date: 2021-09-06 Impact factor: 2.216

Review 3. The Landscape of Glucose-Lowering Therapy and Cardiovascular Outcomes: From Barren Land to Metropolis.

Authors: Mona P Nasrallah; Charbel Abi Khalil; Marwan M Refaat
Journal: Biomed Res Int Date: 2017-11-14 Impact factor: 3.411

Review 4. Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials.

Authors: Deborah Hinnen; Davida F Kruger
Journal: Diabetes Metab Syndr Obes Date: 2019-04-04 Impact factor: 3.168

5. PPARγ-Independent Side Effects of Thiazolidinediones on Mitochondrial Redox State in Rat Isolated Hearts.

Authors: Matthias L Riess; Reem Elorbany; Dorothee Weihrauch; David F Stowe; Amadou K S Camara
Journal: Cells Date: 2020-01-20 Impact factor: 6.600

5 in total